Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.

Slides:



Advertisements
Similar presentations
Improving diagnosis TB laboratory strengthening.
Advertisements

Tuberculosis in Children: Prevention Module 10C - March 2010.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
Monitoring and Evaluation: Tuberculosis Control Programs
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
Miriam Nuño Harvard School of Public Health, USA Gerardo Chowell Los Alamos National Laboratory, USA Abba Gumel University of Manitoba, Canada AIMS/DIMACS/SACEMA.
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Unit 5: Core Elements of HIV/AIDS Surveillance
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Lecture 3: Data sources Health inequality monitoring: with a special focus on low- and middle-income countries.
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
Pakistan.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
Departmental Perspectives on Viral Hepatitis
1 TB/HIV Project in the Philippines Yumiko Yanase.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
A Valuable Resource: Health Sector as a Beneficiary and Contributor to CRVS Systems.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
Public Health Surveillance
Application in professional activity of theoretical knowledge and practical skills acquired during residency program Dr. Ion Bîrcă National Center of Public.
eHARS to CAREWare Pilot Project Update and Training
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
Project Goals  Support the National Tb Program (NTP)  Developed National Guidelines for prevention and control of Tb  Developed guidelines for treating.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Early TB detection and treatment efficiency enhancement among the most at risk populations in Ukraine AIDS 2014, Melbourne 22 July 2014.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Sri Lankan Perspective Dr Nihal Abeysinghe M.B.,B.S., MSc, M.D. (Community Medicine) Chief Epidemiologist Ministry of Health, Nutrition & Welfare Place.
Lucile de Comarmond Chief Pharmacist Workshop on Impact of TRIPS/IP on Access to Medicine September 2014.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.
Using Informatics to Promote Community/Population Health
Unit 6: Specialised Techniques: Anti-Microbial Resistance Monitoring and Assessment of STI Syndrome Aetiologies #4-6-1.
Review in slides Indonesia
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Introduction to US Health Care Unit 4 Chapter 14 Public Health Policy 14-1.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Transport Against HIV/AIDS in Cambodia Maria Margarita Nunez EASTE 28 November 2007.
Update from the 2010 National Influenza Vaccine Summit meeting L.J Tan Co-chair, National Influenza Vaccine Summit Director, Medicine and Public Health,
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
M O N T E N E G R O Negotiating Team for Accession of Montenegro to the European Union Working Group for Chapter 18 – Statistics Bilateral screening: Chapter.
TANZANIA MAINLAND NATIONAL HEALTH POLICY AND STRATEGY REPORT.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
1 Disaster epidemiology Professor Vilius Grabauskas Kaunas University of Medicine, Kaunas, Lithuania NATO supported advanced research workshop, Kaunas,
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
TB- HIV Collaborative activities in Romania- may 2006 status
World Tuberculosis Day 2014
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Disaster epidemiology
TB epidemiological situation in Kyrgyzstan
Presentation transcript:

Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety Division Bureau of Social Welfare and Public Health Tokyo Metropolitan Government February 5, 2014

1 Conducting a Current Situation Survey Background (1) As five years have passed since the compilation of the 2009 Infectious Diseases Situation Survey, an update is needed. (2) While information on the current situation of HIV/AIDS for each country as a whole is available, there is little information regarding individual cities.

2 Conducting a Current Situation Survey Objectives (1) To update the 2009 Infectious Diseases Situation Survey in order to share the current situation regarding infectious diseases in the member cities. (2) To share the current situation and measures against HIV/AIDS in each city in order to consider what exactly to implement for Joint Research and Survey starting from 2015.

3 Infectious Diseases Situation Survey (Draft) Implementation Details (1) Update information of the 2009 Infectious Diseases Situation Survey. (Four Contents) (2) For the matters related to HIV/AIDS, conduct a detailed survey in preparation for Joint Research and Survey. Also, conduct particularly detailed surveys on healthcare service systems and activities for public awareness.

4 Infectious Diseases Situation Survey (Draft) Method: (1) The Infectious Diseases Situation Survey will be conducted by a questionnaire method. (2) Tokyo will send a questionnaire to the member cities by . (3) The member cities will reply the questionnaire to Tokyo. (4) Based on the collected replies, Tokyo will compile a report on the current situation and measures against infectious diseases. (5) The findings of the survey will be shared at the conference, while the report will be distributed to the member cities.

5 Four Contents (Draft) A. Outline of Healthcare Basic Demographic Feature Areas and Population Fertility profile Mortality profile System of Health Governance and Health Resources Health service system in your country including your city Health Insurance Organizational chart of your city Health-related administrative organization of your city Health infrastructure Overall of Infectious Diseases Control Mortality and morbidity of communicable diseases (per year) Immunization Coverage (%) Surveillance system for infectious diseases given by law(s) *For the overview of healthcare, the survey will contain the same items as that of 2009.

6 B. HIV/AIDS Administration Morbidity and Mortality Counseling and Testing Number of special hospitals for HIV/AIDS treatment The number of questions related to HIV/AIDS will be increased. 1. Surveillance for HIV/AIDS 2. Situation of Infection and patient trends 3. Roles and responsibilities of relevant agencies regarding HIV/AIDS 4. Counseling and Testing 5. Healthcare service system 6. Activities for public awareness Four Contents (Draft)

7 C. Tuberculosis (TB) Administration Administrative response at detecting TB cases Records and reporting system for health administration BCG Age or month for BCG vaccination BCG coverage Number of TB cases and rate (per 100,000 population) Number of notification, incidence, prevalence, deaths, successfully treated (country, city) DOTS Strategy Compliance of DOTS strategy Target patients for implementing DOTS Percent of population covered by DOTS Resources for diagnostic services by laboratories 1) sputum smear, 2) culture, 3) drug susceptibility test, 4) QFT, 5) RFLP, 6) VNTR Surveillance for MDR/XDR-TB Number of MDR-Tb patients, the number of treated in DOTS-Plus programs * For TB, the survey will contain the same items as that of Four Contents (Draft)

8 D. Pandemic Influenza Pandemic preparedness plan Expectations on availability of pandemic vaccine Expectations on availability of antivirals Status of planning for antivirals and pandemic vaccine 1) Monitoring antiviral use & adverse events 2) Strategies for antiviral drug delivery 3) Priority groups for antiviral treatment 4) Monitoring use & adverse events of pandemic vaccine 5) Strategies for vaccine delivery 6) Priority groups for vaccination Resources on testing and surveillance Types of laboratory which can detect a novel influenza subtype Data sources of syndromic surveillance for early detection of outbreak *For pandemic influenza, the survey will contain the same items as that of Four Contents (Draft)

9 1. Surveillance for HIV/AIDS ・ Types of surveillance (1) notifiable (2) sentinel (3) pathogens B. HIV/AIDS (Draft)

10 2. Situation of infection and patient trends (Both national and city statistics) (1) Cumulative number of HIV/AIDS reported (2) Annual trend in numbers of newly infected HIV/AIDS cases (3) Number of newly infected HIV/AIDS cases (total, by sex, by age, by infection route) (4) Number of deaths due to AIDS B. HIV/AIDS (Draft)

11 B. HIV/AIDS (Draft) 3. Roles and responsibilities of relevant agencies regarding HIV/AIDS (1) Public health organizations (2) Healthcare providers (3) NGOs (4) Others

12 B. HIV/AIDS (Draft) 4. Counseling and Testing (1) HIV testing facilities (types, number) (2) Testing available at each facility (types) (3) Number of testing conducted at each facility (per year) (4) Number of HIV positive results (5) Fees for receiving HIV testing

13 B. HIV/AIDS (Draft) 5. Healthcare service system (1) Public agencies in charge of HIV/AIDS (number, types) (2) NGOs related to HIV/AIDS number, types: (a) activities for public awareness (b) testing (c) support (3) Regional plan or guideline on HIV/AIDS

14 B. HIV/AIDS (Draft) (4) Medical care (a) Number of specialized healthcare providers (b) HIV/AIDS treatment fees (public assistance, health insurance) (c) Flow chart of testing  examination at a healthcare provider  medical prescription  treatment support and consultation (5) Treatment support (a) By public agencies (b) Healthcare providers (c) NGOs

15 B. HIV/AIDS (Draft) 6. Activities for Public Awareness (1) For general population (2) For specific groups Each city selects two or more of the following groups, on which it is focusing most: (a) MSM (b) CSW (c) youths (d) mother-to-child transmission (e) drug users

16 Infectious Diseases Situation Survey (Draft) Questionnaire (March) Submit (B. HIV/AIDS) (May) Submit (A,C and D) (November) Report (Early in 2015) Implementation Schedule in 2014 Tokyo The member cities

17 (1) In 2009, Infectious Diseases Situation Survey was conducted in order to understand and share the current situation regarding infectious diseases in the member cities. (2) Participating cities: Bangkok, Hanoi, Seoul, Singapore, Taipei, Tokyo 2009 Infectious Diseases Situation Survey

Infectious Diseases Situation Survey (3) Method Questionnaire method (4) Survey period From March to April in 2008

Infectious Diseases Situation Survey (5) Survey Items ・ Outline of Healthcare ・ Administrative summary ・ HIV/AIDS ・ Tuberculosis ・ Pandemic influenza ・ Expecting themes on the joint research

20 Thank you!